留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

肾移植术后JC病毒感染的最新进展

贺裕 欧志宇 苗芸

贺裕, 欧志宇, 苗芸. 肾移植术后JC病毒感染的最新进展[J]. 器官移植, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017
引用本文: 贺裕, 欧志宇, 苗芸. 肾移植术后JC病毒感染的最新进展[J]. 器官移植, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017
He Yu, Ou Zhiyu, Miao Yun. The latest progress on JC virus infection after renal transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017
Citation: He Yu, Ou Zhiyu, Miao Yun. The latest progress on JC virus infection after renal transplantation[J]. ORGAN TRANSPLANTATION, 2021, 12(4): 484-488. doi: 10.3969/j.issn.1674-7445.2021.04.017

肾移植术后JC病毒感染的最新进展

doi: 10.3969/j.issn.1674-7445.2021.04.017
基金项目: 

国家自然科学基金 8207032973

广东省自然科学基金 2020A1515010674

广州市科技计划项目 201803010109

南方医院院长基金 2018B009

南方医院院长基金 2018C003

大学生创新创业训练计划项目 202012121046

大学生创新创业训练计划项目 X202012121239

详细信息
    作者简介:

    贺裕,女,1996年生,硕士研究生,研究方向为肾移植,Email:771467605@qq.com

    通讯作者:

    苗芸,女,1978年生,博士,主任医师,研究方向为肾移植,Email:miaoyunecho@126.com

  • 中图分类号: R617, R373

The latest progress on JC virus infection after renal transplantation

More Information
  • 摘要: JC病毒(JCV)是多瘤病毒家族的成员之一,在人群中的感染率约为70%,初次感染后常潜伏存在。在免疫抑制的个体中,特别是细胞免疫功能低下的情况下,JCV可以重新激活并导致严重的临床表现。近年来,JCV与肾移植术后并发症的相关性逐渐被重视,已有JCV相关性肾病(JCVAN)的报道。现就JCV的流行病学、分子生物学、体内感染过程,JCV与肾移植术后并发症以及JCV与BKV的相互关系进行综述,以期为肾移植术后免疫抑制方案的调整提供参考。

     

  • [1] TORRES C. Evolution and molecular epidemiology of polyomaviruses[J]. Infect Genet Evol, 2020, 79: 104150. DOI: 10.1016/j.meegid.2019.104150.
    [2] ATKINSON AL, ATWOOD WJ. Fifty years of JC polyomavirus: a brief overview and remaining questions[J]. Viruses, 2020, 12(9): 969. DOI: 10.3390/v12090969.
    [3] MAYBERRY CL, MAGINNIS MS. Taking the scenic route: polyomaviruses utilize multiple pathways to reach the same destination[J]. Viruses, 2020, 12(10): 1168. DOI: 10.3390/v12101168.
    [4] MAZZONI E, PELLEGRINELLI E, MAZZIOTTA C, et al. Mother-to-child transmission of oncogenic polyomaviruses BKPyV, JCPyV and SV40[J]. J Infect, 2020, 80(5): 563-570. DOI: 10.1016/j.jinf.2020.02.006.
    [5] FORNI D, CAGLIANI R, CLERICI M, et al. You will never walk alone: codispersal of JC polyomavirus with human populations[J]. Mol Biol Evol, 2020, 37(2): 442-454. DOI: 10.1093/molbev/msz227.
    [6] BERGER JR, DANAHER RJ, DOBBINS J, et al. Dynamic expression of JC virus in urine and its relationship to serostatus[J]. Mult Scler Relat Disord, 2020, 41: 101972. DOI: 10.1016/j.msard.2020.101972.
    [7] MAHLER C, SCHUMACHER AM, UNTERRAINER M, et al. TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy[J]. Brain, 2021, DOI: 10.1093/brain/awab127[Epub ahead of print].
    [8] SEPPÄLÄ HM, HELANTERÄ IT, LAINE PKS, et al. Archetype JC polyomavirus (JCPyV) prevails in a rare case of JCPyV nephropathy and in stable renal transplant recipients with JCPyV viruria[J]. J Infect Dis, 2017, 216(8): 981-989. DOI: 10.1093/infdis/jix435.
    [9] AGUILAR J, CHANG DH, LIN M, et al. JC virus-associated nephropathy in a post-heart and -kidney transplantation patient[J]. Transpl Infect Dis, 2020, 22(3): e13288. DOI: 10.1111/tid.13288.
    [10] WIEGLEY N, WALAVALKAR V, AUJLA H, et al. Clinicopathologic characteristics of JC virus nephropathy in kidney transplant recipients[J]. Transplantation, 2020, 105(5): 1069-1076. DOI: 10.1097/TP.0000000000003363.
    [11] QUERIDO S, FERNANDES I, WEIGERT A, et al. High-grade urothelial carcinoma in a kidney transplant recipient after JC virus nephropathy: the first evidence of JC virus as a potential oncovirus in bladder cancer[J]. Am J Transplant, 2020, 20(4): 1188-1191. DOI: 10.1111/ajt.15663.
    [12] ULERI E, PIU C, CAOCCI M, et al. Multiple signatures of the JC polyomavirus in paired normal and altered colorectal mucosa indicate a link with human colorectal cancer, but not with cancer progression[J]. Int J Mol Sci, 2019, 20(23): 5965. DOI: 10.3390/ijms20235965.
    [13] REOMA LB, TRINDADE CJ, MONACO MC, et al. Fatal encephalopathy with wild-type JC virus and ruxolitinib therapy[J]. Ann Neurol, 2019, 86(6): 878-884. DOI: 10.1002/ana.25608.
    [14] CIARDI MR, ZINGAROPOLI MA, IANNETTA M, et al. JCPyV NCCR analysis in PML patients with different risk factors: exploring common rearrangements as essential changes for neuropathogenesis[J]. Virol J, 2020, 17(1): 23. DOI: 10.1186/s12985-020-1295-5.
    [15] SIGNORINI L, DOLCI M, FAVI E, et al. Viral genomic characterization and replication pattern of human polyomaviruses in kidney transplant recipients[J]. Viruses, 2020, 12(11): 1280. DOI: 10.3390/v12111280.
    [16] LAUVER MD, LUKACHER AE. JCPyV VP1 mutations in progressive multifocalleukoencephalopathy: altering tropismor mediating immune evasion?[J]. Viruses, 2020, 12(10): 1156. DOI: 10.3390/v12101156.
    [17] SOLIS M, GUFFROY A, LERSY F, et al. Inadequate immune humoral response against JC virus in progressive multifocal leukoencephalopathy non-survivors[J]. Viruses, 2020, 12(12): 1380. DOI: 10.3390/v12121380.
    [18] SCHNEIDEWIND L, NEUMANN T, DRÄGER DL, et al. Leflunomide in the treatment of BK polyomavirus associated nephropathy in kidney transplanted patients -a systematic review[J]. Transplant Rev (Orlando), 2020, 34(4): 100565. DOI: 10.1016/j.trre.2020.100565.
    [19] LAUTENSCHLAGER I, JAHNUKAINEN T, KARDAS P, et al. A case of primary JC polyomavirus infection-associated nephropathy[J]. Am J Transplant, 2014, 14(12): 2887-2892. DOI: 10.1111/ajt.12945.
    [20] KANTARCI G, EREN Z, DEMIRAĞ A, et al. JC virus-associated nephropathy in a renal transplant recipient and comparative analysis of previous cases[J]. Transpl Infect Dis, 2011, 13(1): 89-92. DOI: 10.1111/j.1399-3062.2010.00567.x.
    [21] WEN MC, WANG CL, WANG M, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient[J]. J Med Virol, 2004, 72(4): 675-678. DOI: 10.1002/jmv.20037.
    [22] FREEDMAN BI, KISTLER AL, SKEWES-COX P, et al. JC polyoma viruria associates with protection from chronic kidney disease independently from apolipoprotein L1 genotype in African Americans[J]. Nephrol Dial Transplant, 2018, 33(11): 1960-1967. DOI: 10.1093/ndt/gfx368.
    [23] CHENG XS, BOHL DL, STORCH GA, et al. Inhibitory interactions between BK and JC virus among kidney transplant recipients[J]. J Am Soc Nephrol, 2011, 22(5): 825-831. DOI: 10.1681/ASN.2010080877.
    [24] RAY U, CINQUE P, GEREVINI S, et al. JC polyomavirus mutants escape antibody-mediated neutralization[J]. Sci Transl Med, 2015, 7(306): 306ra151. DOI: 10.1126/scitranslmed.aab1720.
    [25] BERZERO G, BASSO S, STOPPINI L, et al. Adoptive transfer of JC virus-specific T lymphocytes for the treatment of progressive multifocal leukoencephalopathy[J]. Ann Neurol, 2021, 89(4): 769-779. DOI: 10.1002/ana.26020.
    [26] HUSSAIN I, TASNEEM F, GILANI US, et al. Human BK and JC polyomaviruses: molecular insights and prevalence in Asia[J]. Virus Res, 2020, 278: 197860. DOI: 10.1016/j.virusres.2020.197860.
    [27] LIAW YC, CHEN CH, SHU KH, et al. Recombined sequences between the non-coding control regions of JC and BK viruses found in the urine of a renal transplantation patient[J]. Virus Genes, 2012, 45(3): 581-584. DOI: 10.1007/s11262-012-0815-9.
  • 加载中
图(1)
计量
  • 文章访问数:  208
  • HTML全文浏览量:  43
  • PDF下载量:  26
  • 被引次数: 0
出版历程
  • 收稿日期:  2021-04-19
  • 网络出版日期:  2021-07-13
  • 刊出日期:  2021-07-15

目录

    /

    返回文章
    返回